Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹187 Cr.
Stock P/E
26.1
P/B
3
Current Price
₹177.6
Book Value
₹ 59.5
Face Value
10
52W High
₹335
52W Low
₹ 147
Dividend Yield
0%

Vaidya Sane Ayur Lab Overview

Business

Vaidya Sane Ayurved Laboratories Ltd. is an Indian company operating in the Hospital & Healthcare Services sector, specifically focused on Ayurvedic medicine. The company's core business revolves around providing healthcare services based on traditional Ayurvedic principles. This typically includes patient consultations, various Ayurvedic therapies (Panchakarma, etc.), and potentially manufacturing and selling Ayurvedic medicines, herbal supplements, and wellness products. Its business model generates revenue through fees for medical consultations, income from therapeutic procedures, and sales of proprietary or traditional Ayurvedic products.

Revenue Mix

While specific revenue breakdown is not publicly available without detailed financial reports, the company's revenue streams likely originate from:

Clinic Services: Consultations with Ayurvedic doctors, diagnosis, and treatment plans.

Therapeutic Services: Income from various Ayurvedic therapies and wellness programs offered at their centers.

Product Sales: Sales of Ayurvedic medicines, nutraceuticals, personal care products, and health supplements under their brand.

Clinic and therapeutic services likely form a significant portion, complemented by product sales.

Industry

The company operates within the growing Indian healthcare services sector, with a specific focus on the AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, Homoeopathy) segment. The AYUSH market in India is fragmented, comprising numerous small clinics, individual practitioners, and a few larger organized players. Vaidya Sane Ayurved Laboratories Ltd. likely positions itself as a specialized provider of authentic Ayurvedic treatments and products, leveraging its "Vaidya Sane" brand. Its competitive landscape includes other standalone Ayurvedic clinics, larger multi-specialty hospitals that may offer AYUSH departments, and companies focused solely on manufacturing and selling Ayurvedic products.

MOAT

Brand Reputation: A long-standing presence or strong historical foundation could have built trust and recognition for the "Vaidya Sane" name within the Ayurvedic community and among patients seeking traditional remedies.

Specialized Expertise: Deep knowledge and expertise in traditional Ayurvedic diagnosis and treatment protocols can attract patients seeking specialized and holistic care.

Proprietary Formulations: If the company has developed unique or highly effective Ayurvedic formulations, these could provide a soft moat, though traditional Ayurvedic knowledge is largely open source.

Patient Loyalty: For chronic conditions treated with Ayurveda, patients often develop loyalty to specific practitioners or clinics, leading to repeat business.

Growth Drivers

Increasing Acceptance of AYUSH: Growing public awareness and government initiatives promoting AYUSH are driving demand for Ayurvedic treatments and products.

Rising Health Consciousness: A global trend towards preventive healthcare, natural remedies, and holistic wellness benefits Ayurvedic providers.

Lifestyle Diseases: Ayurveda often offers effective, holistic approaches for managing chronic lifestyle-related disorders, expanding its target patient base.

Expansion of Clinics/Product Portfolio: Opening new centers, increasing geographical reach, and diversifying product offerings can fuel growth.

Medical Tourism: India's potential as an Ayurvedic medical tourism destination could attract international patients.

Risks

Regulatory Changes: Evolving regulations by AYUSH ministry or food safety authorities regarding product manufacturing, claims, and practice standards could impact operations.

Reputational Risk: Negative publicity from adverse patient outcomes, product quality issues, or unproven efficacy claims can severely damage brand trust.

Intense Competition: High competition from numerous established and new Ayurvedic clinics, product manufacturers, and even modern medicine providers offering integrated approaches.

Talent Scarcity: Difficulty in finding and retaining highly skilled and experienced Ayurvedic doctors and therapists.

Standardization & Quality Control: Ensuring consistent quality and efficacy across services and products can be challenging, particularly in a traditional medicine system.

Management & Ownership

As an Indian company, it is likely promoter-driven, typical for many family-run or founder-led businesses in India. The "Vaidya Sane" name suggests a lineage or a respected founder, often implying a deep commitment to the traditional practice. Specific details about the current management team's professional background, corporate governance practices, or granular ownership structure beyond promoter holding are not available from the provided prompt.

Outlook

Vaidya Sane Ayurved Laboratories operates in a sector with significant tailwinds, driven by increasing consumer preference for natural remedies and government support for traditional medicine. This positions the company favorably to capitalize on the growing demand for Ayurvedic healthcare services and products. However, the company faces inherent challenges including intense competition, the need for robust quality control, and potential regulatory scrutiny common in the AYUSH sector. Sustained growth will depend on its ability to effectively scale operations, maintain brand trust, innovate within traditional frameworks, and navigate the fragmented and evolving healthcare landscape while ensuring the efficacy and safety of its offerings.

Vaidya Sane Ayur Lab Share Price

Live · NSE · Inception: 1999
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Vaidya Sane Ayur Lab Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Vaidya Sane Ayur Lab Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 99 99 90
Other Income 1 2 2
Total Income 101 101 92
Total Expenditure 91 95 76
Operating Profit 10 6 15
Interest 1 0 0
Depreciation 3 3 4
Exceptional Income / Expenses 0 0 -1
Profit Before Tax 6 3 10
Provision for Tax 2 1 3
Profit After Tax 5 2 7
Adjustments 0 -0 -0
Profit After Adjustments 5 2 7
Adjusted Earnings Per Share 4.6 1.9 6.8

Vaidya Sane Ayur Lab Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 40 56 63
Minority's Interest 0 0 0
Borrowings 0 0 0
Other Non-Current Liabilities 1 2 3
Total Current Liabilities 13 12 11
Total Liabilities 55 70 77
Fixed Assets 21 28 34
Other Non-Current Assets 6 10 13
Total Current Assets 28 31 30
Total Assets 55 70 77

Vaidya Sane Ayur Lab Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 3 2 2
Cash Flow from Operating Activities 0 -1 11
Cash Flow from Investing Activities 1 -13 -10
Cash Flow from Financing Activities -1 15 -1
Net Cash Inflow / Outflow -1 1 -0
Closing Cash & Cash Equivalent 2 2 2

Vaidya Sane Ayur Lab Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.6 1.88 6.78
CEPS(Rs) 7.07 4.88 10.75
DPS(Rs) 0.25 0 0
Book NAV/Share(Rs) 38.48 40.1 59.44
Core EBITDA Margin(%) 8.6 4.54 15.17
EBIT Margin(%) 7.35 3.14 11.27
Pre Tax Margin(%) 6.49 2.88 11.02
PAT Margin (%) 4.87 2 7.96
Cash Profit Margin (%) 7.49 5.17 12.59
ROA(%) 8.82 3.2 9.78
ROE(%) 11.95 4.82 13.66
ROCE(%) 17.96 6.37 16.7
Receivable days 22.05 22.12 27.6
Inventory Days 12.56 13.83 15.99
Payable days 118.46 114.04 152.09
PER(x) 51.12 92.39 13.81
Price/Book(x) 6.11 4.34 1.58
Dividend Yield(%) 0.11 0 0
EV/Net Sales(x) 2.47 1.84 1.09
EV/Core EBITDA(x) 24.82 29.11 6.31
Net Sales Growth(%) 0 0.16 -9.55
EBIT Growth(%) 0 -57.21 224.59
PAT Growth(%) 0 -58.81 259.44
EPS Growth(%) 0 -59.03 260.17
Debt/Equity(x) 0 0.04 0.02
Current Ratio(x) 2.16 2.7 2.7
Quick Ratio(x) 1.89 2.34 2.36
Interest Cover(x) 8.5 12.25 44.76
Total Debt/Mcap(x) 0 0.01 0.01

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -9% — — —
Operating Profit CAGR +150% — — —
PAT CAGR +250% — — —
Share Price CAGR -38% -17% — —
ROE Average +14% +10% +10% +10%
ROCE Average +17% +14% +14% +14%

Vaidya Sane Ayur Lab Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 66.34 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 33.66 %
# Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 66.3466.3466.3466.3466.3466.3466.3466.3466.3466.34
FII 0000000000
DII 00000000.2100
Public 33.6633.6633.6633.6633.6633.6633.6633.4533.6633.66
Others 0000000000
Total 100100100100100100100100100100

Vaidya Sane Ayur Lab Peer Comparison

Hospital & Healthcare Services Edit Columns

Vaidya Sane Ayur Lab Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Vaidya Sane Ayur Lab Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 10% over the last 3 years.
  • Debtor days have increased from 114.04 to 152.09days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp